Altimmune (ALT) EBIT Margin Growth (5y) (2015 - 2025)
Altimmune (ALT) EBIT Margin Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Altimmune | 7.96 Mn | 7.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.07 Mn |
| Sep 30, 2025 | -41.66 Mn |
| Jun 30, 2025 | -45.80 Mn |
| Mar 31, 2025 | -43.60 Mn |
| Dec 31, 2024 | -49.66 Mn |
| Sep 30, 2024 | -49.36 Mn |
| Jun 30, 2024 | -53.47 Mn |
| Mar 31, 2024 | -53.58 Mn |
| Dec 31, 2023 | -8.98 Mn |
| Sep 30, 2023 | -607,248.00 |
| Jun 30, 2023 | -29.99 Mn |
| Mar 31, 2023 | -10.34 Mn |
| Dec 31, 2022 | -8.81 Mn |
| Sep 30, 2022 | -123.69 Mn |
| Jun 30, 2022 | -25.48 Mn |
| Mar 31, 2022 | -5.94 Mn |
| Dec 31, 2021 | -23,946.00 |
| Sep 30, 2021 | -2.05 Mn |
| Jun 30, 2021 | -1.79 Mn |
| Mar 31, 2021 | -164,866.00 |